Rohan Gene Cell Tech
Our team was assembled in 2017 to provide unbiased, scientifically-sound treatment options with stem cells, biobanking and tissue engineering. The organization arose from the unmet need to provide stem cell therapies that have been shown by others to meet the bar of safety, but are not yet widely available worldwide. Rohan activity will be soon started in 2018 saving stem cells from all tissue sources for biobanking including adipose tissue, bone marrow, dental pulp, cord and peripheral blood, etc. to reach a valuable biobanking not only in the country but also in the Middle East Region. Scaffold provided in Rohan will be beneficial for cell transplantation and tissue injuries. We intend to extend our activity with an equipped high tech tissue bank too. Our scientists in Rohan Gene Cell Tech have several publications that exceed 600 papers in international peer reviewed medical journals and have several patents too. Our goal is on clinical use of stem cells and banking using tissue engineering in therapies. We routinely interact with colleagues nationally and internationally who are using stem cells as part of clinical trials in order to incorporate the most recent advancements into patient care. We are eager to share our experiences with educational. clinical and research centers who work on stem cell technology. At our Co., our mission is to be at the forefront of research of cell banking and new treatment protocols for acute and chronic diseases using adult stem cells, always according to the highest international bioethics standards, and offering, with transparency, honesty and human quality, treatments developed to improve the condition of our patients that we are honor about.